Astellas Pharma Financial Overview
Astellas Pharma's market cap is currently $24.14B. The company's EPS TTM is $0.28561698; its P/E ratio is 28.20; and it has a dividend yield of 3.75%. Astellas Pharma is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is $0.28. See an overview of income statement, balance sheet, and cash flow financials.
